In a 2017 study by Malla et al. [119] (Table 3), 100 neonates with moderate or severe HIE were recruited to a randomized study investigating the effectiveness and long-term outcomes of repeated doses of EPO alone, when HT is unavailable (e.g., in resource poor settings). The gene discussed is EPO; the disease is perinatal asphyxia.